Literature DB >> 30390124

Clinical significance of the timing of early recurrence of atrial arrhythmia after pulmonary vein isolation: a two-institution clinical study.

Yosuke Murase1, Yasuya Inden2, Hajime Imai1, Seifuku Kyo1, Satoshi Yanagisawa3, Aya Fujii3, Yusuke Sakamoto3, Toshiro Tomomatsu3, Toyoaki Murohara3.   

Abstract

Early recurrence of atrial arrhythmia (ERAA) after ablation frequently occurs, but there is limited evidence about ERAA-timing. This study aimed to investigate the association between ERAA-timing and late recurrence. We retrospectively investigated 332 patients who underwent PVI for paroxysmal atrial fibrillation at Nagoya University Hospital and Komaki City Hospital. Seventy-six patients (23%) had ERAA. The cutoff value of the first ERAA for late recurrence was set as 3 days, with a specificity of 77% and sensitivity of 43%. On multivariate analysis, first ERAA beyond 3 days (hazard ratio, 2.477; 95% confidence interval, 1.168-5.25; p = 0.018) and large left atrial diameter (LAD) (hazard ratio, 1.101; 95% confidence interval, 1.024-1.184; p = 0.009) were independent predictors for late recurrence. Patients who had first ERAA within 3 days and no ERAA beyond 3 days showed a significantly higher recurrence-free rate than those who had first ERAA beyond 3 days and those who had ERAA both within 3 days and beyond 3 days (89% versus 39%, 44%; p  < 0.001). Moreover, the patients with ERAA within 3 days and LAD ≤ 37.7 mm showed a significantly higher recurrence-free rate than those with ERAA beyond 3 days and LAD > 37.7 mm, and as compared with the other patients (100% versus 26% and 60%, respectively; p < 0.001). ERAA beyond 3 days after ablation was a predictor for late recurrence. Among patients with ERAA, those with ERAA within 3 days and smaller LAD showed favorable prognosis after ablation.

Entities:  

Keywords:  Atrial arrhythmia recurrence; Catheter ablation; Early recurrence; Left atrial diameter; Paroxysmal atrial fibrillation

Mesh:

Year:  2018        PMID: 30390124     DOI: 10.1007/s00380-018-1295-1

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  21 in total

1.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

4.  Recurrence of atrial tachyarrhythmia during the second month of the blanking period is associated with more extensive pulmonary vein reconnection at repeat electrophysiology study.

Authors:  Moloy Das; Gareth J Wynn; Maureen Morgan; Ben Lodge; Johan E P Waktare; Derick M Todd; Mark C S Hall; Richard L Snowdon; Simon Modi; Dhiraj Gupta
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-06-24

5.  Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation.

Authors:  Emanuele Bertaglia; Giuseppe Stabile; Gaetano Senatore; Franco Zoppo; Pietro Turco; Claudia Amellone; Antonio De Simone; Massimo Fazzari; Pietro Pascotto
Journal:  Pacing Clin Electrophysiol       Date:  2005-05       Impact factor: 1.976

6.  Incidence and significance of early recurrences associated with different ablation strategies for AF: a STAR-AF substudy.

Authors:  Jason G Andrade; Laurent Macle; Paul Khairy; Yaariv Khaykin; Roberto Mantovan; Giuseppe De Martino; Jian Chen; Carlos A Morillo; Paul Novak; Peter G Guerra; Girish Nair; Esteban G Torrecilla; Atul Verma
Journal:  J Cardiovasc Electrophysiol       Date:  2012-08-17

7.  Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome.

Authors:  Timir S Baman; Sanjaya K Gupta; Sreedhar R Billakanty; Karl J Ilg; Eric Good; Thomas Crawford; Krit Jongnarangsin; Matt Ebinger; Frank Pelosi; Frank Bogun; Aman Chugh; Fred Morady; Hakan Oral
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12

8.  Comparison of characteristics and significance of immediate versus early versus no recurrence of atrial fibrillation after catheter ablation.

Authors:  Takashi Koyama; Yukio Sekiguchi; Hiroshi Tada; Takanori Arimoto; Hiro Yamasaki; Kenji Kuroki; Takeshi Machino; Kazuko Tajiri; Xu Dong Zhu; Miyako Kanemoto; Aiko Sugiyasu; Keisuke Kuga; Kazutaka Aonuma
Journal:  Am J Cardiol       Date:  2009-03-09       Impact factor: 2.778

9.  Clinical significance of early recurrence after pulmonary vein antrum isolation in paroxysmal atrial fibrillation -- insight into the mechanism.

Authors:  Shinsuke Miyazaki; Hiroshi Taniguchi; Hiroaki Nakamura; Takamitsu Takagi; Jin Iwasawa; Hitoshi Hachiya; Yoshito Iesaka
Journal:  Circ J       Date:  2015-09-07       Impact factor: 2.993

10.  Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome.

Authors:  Bernhard Richter; Marianne Gwechenberger; Ariel Socas; Manfred Marx; Heinz David Gössinger
Journal:  Am J Cardiol       Date:  2008-01-18       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.